Latest Breaking News On - Didier laurens - Page 5 : vimarsana.com

Advicenne Announces 51% Growth in Sibnayal® Gross Sales in H1 2023 to almost €1 0 Million

Advicenne first-half 2023 gross sales1 up 23% to 2.2 million eurosSales of Sibnayal® (potassium citrate/potassium hydrogen carbonate) up 128% in volume termsSibnayal® becomes the Group's leading sales contributorPARIS (BUSINESS WIRE) Regulatory News:Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a special.

United kingdomFrance generalDidier laurensAdvicenne euronextHealth administrationsEuropean renal associationHealth administrationRegulatory newsEuronext growth parisChief executive officerEastern europeanMiddle eastMarketing approvalEuronext parisRegistration document

Advicenne Announces Long-Term Results of the European Clinical Development Program for ADV7103

Regulatory News: Advicenne(Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering

Vilniaus apskritisFrance generalMarta giaccariAdvicenne euronextDidier laurensEuropean renal associationEuropean society of pediatric nephrologyRegulatory newsEuronext growth parisRenal tubular acidosisRenal associationFocused oralsPediatric nephrologyEuropean societyMarketing approvalEuronext paris

Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting

Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalDidier laurensAdvicenne euronextCombined general meetingEuronext growth parisFaubourg saint honorGeneral meetingPhilippe boucheronMarketing approvalEuronext parisRegistration document

Advicenne : Inside Information / Other news releases

Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting Paris , June 9, 2023 - 8.00 am CET - The. | June 9, 2023

France generalAdvicenne euronextDidier laurensCombined general meetingEuronext growth parisFaubourg saint honorGeneral meetingPhilippe boucheronMarketing approvalEuronext parisAdvicenne stock exchangePress releaseEt aldvi fr0013296746

Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combi

PARIS (BUSINESS WIRE) Regulatory News:The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, met on June 8, 2.

France generalAdvicenne euronextDidier laurensRegulatory newsCombined general meetingEuronext growth parisFaubourg saint honorGeneral meetingPhilippe boucheronMarketing approvalEuronext parisRegistration document